Cosmos Holdings, Inc. Announces Year End 2018 Financial Results
Revenue Improved 23.6% and Gross Profit Improved 23.1% compared to 2017
CHICAGO, IL- - April 23, 2018 - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international
pharmaceutical company, announced its full-year 2018 financial results for the year ended December
31, 2018.
2018 Highlights:
? Revenue improved 23.6% to $37 million from $30 million in 2017
? Gross profit increase 23.1% to $2.4 million from $1.96 million in 2017
? Operating expenses decreased by 46.7% year over year.
? Repaid the remaining balance of its convertible notes, totaling $5.5 million.
? Completed the acquisition of Cosmofarm Ltd., www.cosmofarm.gr, a fully licensed
pharmaceutical wholesale company, in December of 2018 which features a fully automated
supply chain and integrated robotic fulfillment center powered by ROWA.
? Entered the Nutraceutical market with its own premium brand of food supplements - Sky
Premium Life.
Grigorios Siokas, Chief Executive Officer commented, “Our focus in 2018 included increasing our core
distribution business, formally launching our Sky Premium Life food supplement brand, expanding our
direct to pharmacy reach, and vertically integrating into our supply chain. Looking to 2019 we will be
focusing on building our Sky Premium Life food supplement brand along with expanding our product
offerings.”
About Cosmos Holdings, Inc.
Cosmos Holdings Inc. is a pharmaceutical wholesaler distributing branded and generic medicines, over-
the-counter (OTC) pharmaceuticals, food supplements, and medical devices to its growing network with
offices and warehouses in Thessaloniki, Greece; Athens, Greece; and Harlow, UK. The Company has a
trans-European network which expands throughout Europe. More information is available at
www.cosmosholdingsinc.com.
FORWARD LOOKING STATEMENTS
Except for historical information, this news release contains forward-looking statements, within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. These statements involve unknown risks, and uncertainties that may cause the Company's actual
results or outcomes to be materially different from those anticipated and discussed herein. Important
factors that might cause such differences are discussed in the Company's filings with the Securities and
Exchange Commission. The Company disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future events or otherwise. Actual
results could differ materially from those anticipated in these forward-looking statements, if new
information becomes available in the future.
